| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO
2 companies
Kumar Ramesh serves as a President And CEO at TRAW and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 7 sells. Those positions are worth an estimated $215K at current prices.
Historically, Kumar Ramesh's trades have earned a strong insider score of 80/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +69.3%.
The biggest single holding is TRAW (~$215K) as President And CEO. Net of sales, the recent Form 4 record there shows accumulation of 23,810 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2022 | OCGN Ocugen, Inc. | Director | Sale+OE | 4,500 | $1.83 | $8,235.00 | -100% | -26.1% | -77.4% | |
| Jul 18, 2022 | OCGN Ocugen, Inc. | Director | Sale+OE | 7,500 | $2.57 | $19,275.00 | -100% | -33.1% | -75.9% | |
| Apr 18, 2022 | OCGN Ocugen, Inc. | Director | Sale+OE | 7,500 | $2.83 | $21,225.00 | -100% | -4.6% | -66.3% | |
| Jan 18, 2022 | OCGN Ocugen, Inc. | Director | Sale+OE | 7,500 | $4.07 | $30,525.00 | -100% | -35.0% | -69.8% | |
| Oct 18, 2021 | OCGN Ocugen, Inc. | Director | Sale+OE | 7,500 | $8.13 | $60,975.00 | -100% | -51.6% | -80.1% | |
| Jul 19, 2021 | OCGN Ocugen, Inc. | Director | Sale+OE | 7,500 | $6.40 | $48,000.00 | -100% | +9.8% | -64.0% | |
| Apr 19, 2021 | OCGN Ocugen, Inc. | Director | Sale+OE | 7,500 | $5.33 | $39,975.00 | -100% | +33.3% | -52.0% | |
| Apr 26, 2017 | TRAW Traws Pharma, Inc. | President And CEO | Buy | 23,810 | $2.10 | $50,001.00 | +30.4% | - | - |